Fox 29: A closer look at the pandemic’s impact on women’s health
August 2, 2021
Dr. Kate Lathrop, Hematology/Mays Cancer Center, was interviewed for this Fox 29 story about the pandemic’s impact on women’s health. Watch story
U.S. News & World Report: Almost all cancer patients respond well to COVID-19 vaccines
July 6, 2021
This U.S. News & World Report article features a new study that shows 94% of patients with cancer respond well to COVID-19 vaccines. Study co-authors are from the Mays Cancer Center and the University of Geneva. Read story.
The Sacramento Bee: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Sacramento Bee addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
The Olympian: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of The Olympian addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
Miami Herald: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Miami Herald addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story
Idaho Statesman: Do COVID vaccines work in people with HIV, cancer or organ transplants? What we know
July 1, 2021
Dr. Dimpy P. Shah, Population Health Sciences/Mays Cancer Center, was included within a story of the Idaho Statesman addressing her research in which 94% of the 131 patients in the study produced antibodies three to four weeks after full vaccination, most of which had solid cancers as opposed to cancers in the blood. Read story